Published in Gene Therapy Weekly, August 29th, 2002
The use of virus-mediated gene transfer in gene therapy is becoming increasingly popular. However, the competent immune system often recognizes the therapy as being foreign and incapacitates transgene delivery and expression through normal immune response mechanisms.
Scientists have theorized that delivering such therapies before the immune system fully develops, that is, to a growing fetus, might defeat that problem. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly